The Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists on Cardiorenal Outcomes: Systematic Review and Meta-analysis.

MLA

Ali, Muhammad Usman, et al. “The Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists on Cardiorenal Outcomes: Systematic Review and Meta-Analysis.” The Canadian Journal of Cardiology, vol. 38, no. 8, Aug. 2022, pp. 1201–10. EBSCOhost, https://doi.org/10.1016/j.cjca.2022.05.011.

APA

Ali, M. U., Mancini, G. B. J., Fitzpatrick-Lewis, D., Lewis, R., Jovkovic, M., Zieroth, S., O’Meara, E., Connelly, K. A., & Sherifali, D. (2022). The Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists on Cardiorenal Outcomes: Systematic Review and Meta-analysis. The Canadian Journal of Cardiology, 38(8), 1201–1210. https://doi.org/10.1016/j.cjca.2022.05.011

Chicago

Ali, Muhammad Usman, G B John Mancini, Donna Fitzpatrick-Lewis, Ruth Lewis, Milos Jovkovic, Shelley Zieroth, Eileen O’Meara, Kim A Connelly, and Diana Sherifali. 2022. “The Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists on Cardiorenal Outcomes: Systematic Review and Meta-Analysis.” The Canadian Journal of Cardiology 38 (8): 1201–10. doi:10.1016/j.cjca.2022.05.011.